Literature DB >> 2567400

Subcutaneous erythropoietin and peritoneal dialysis.

J M Stevens, C A Strong, D O Oliver, C G Winearls, P M Cotes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2567400     DOI： 10.1016/s0140-6736(89)92832-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Treating renal anaemia with recombinant human erythropoietin: practical guidelines and a clinical algorithm.

Authors:  I C Macdougall; R D Hutton; I Cavill; G A Coles; J D Williams
Journal:  BMJ       Date:  1990-03-10

2.  Subcutaneous r-HuEPO therapy in CAPD patients: dose determination and clinical experience.

Authors:  L Janicka; A Ksiazek; I Baranowicz; A Bednarek-Skublewska; P Mierzicki; P Ksiazek
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

Review 3.  The use of erythropoietin in renal failure.

Authors:  I C Macdougall; R D Hutton; G A Coles; J D Williams
Journal:  Postgrad Med J       Date:  1991-01       Impact factor: 2.401

Review 4.  Clinical pharmacokinetics of epoetin (recombinant human erythropoietin).

Authors:  I C Macdougall; D E Roberts; G A Coles; J D Williams
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

5.  Cost benefits of low dose subcutaneous erythropoietin in patients with anaemia of end stage renal disease.

Authors:  M E Stevens; G P Summerfield; A A Hall; C A Beck; A J Harding; J R Cove-Smith; A D Paterson
Journal:  BMJ       Date:  1992-02-22

6.  Effects of azathioprine on response of renal anaemia to subcutaneous recombinant human erythropoietin.

Authors:  J E Howarth; H M Waters; D Shanks; K Hyde; J A Yin; C G Geary; E Anastassiades; D Howarth; R Gokal
Journal:  J Clin Pathol       Date:  1993-01       Impact factor: 3.411

Review 7.  Epoetin (recombinant human erythropoietin). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in anaemia and the stimulation of erythropoiesis.

Authors:  D Faulds; E M Sorkin
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546

8.  The pharmacokinetics of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects.

Authors:  T Salmonson; B G Danielson; B Wikström
Journal:  Br J Clin Pharmacol       Date:  1990-06       Impact factor: 4.335
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.